{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:12:14Z","timestamp":1780535534542,"version":"3.54.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1097\/inf.0000000000001078","type":"journal-article","created":{"date-parts":[[2016,2,6]],"date-time":"2016-02-06T18:40:54Z","timestamp":1454784054000},"page":"e152-e157","source":"Crossref","is-referenced-by-count":2,"title":["Meningococcal Conjugate and Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccination Among HIV-infected Youth"],"prefix":"10.1097","volume":"35","author":[{"given":"Rosanna W.","family":"Setse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Siberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wheeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly A.","family":"Bohannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210202","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R3-16-20210202","first-page":"61","article-title":"Immunization of children at risk of infection with human immunodeficiency virus.","volume":"81","author":"Moss","year":"2003","journal-title":"Bull World Health Organ"},{"key":"R4-16-20210202","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/1570162043351084","article-title":"Immunization for persons infected with human immunodeficiency virus.","volume":"2","author":"Pancharoen","year":"2004","journal-title":"Curr HIV Res"},{"key":"R5-16-20210202","first-page":"1","article-title":"Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.","volume":"58","author":"Mofenson","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"R6-16-20210202","first-page":"608","article-title":"Use of Serogroup B Meningococcal Vaccines in Persons Aged \u226510 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015.","volume":"64","author":"Folaranmi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-16-20210202","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R9-16-20210202","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","article-title":"Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials.","volume":"369","author":"Ault","year":"2007","journal-title":"Lancet"},{"key":"R10-16-20210202","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"key":"R11-16-20210202","first-page":"1","article-title":"Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"R14-16-20210202","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males\u2014Advisory Committee on Immunization Practices (ACIP), 2011.","volume":"60","author":"Dunne","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R15-16-20210202","first-page":"885","article-title":"National vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2006.","volume":"56","author":"Jain","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R16-16-20210202","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2307\/2061874","article-title":"Prenatal and delivery care and childhood immunization in Guatemala: do family and community matter?","volume":"33","author":"Pebley","year":"1996","journal-title":"Demography"},{"key":"R18-16-20210202","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/jech.2007.060798","article-title":"When can group level clustering be ignored? Multilevel models versus single-level models with sparse data.","volume":"62","author":"Clarke","year":"2008","journal-title":"J Epidemiol Community Health"},{"key":"R20-16-20210202","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/00002030-199407000-00010","article-title":"Pneumococcal and influenza vaccination levels among HIV-infected adolescents and adults receiving medical care in the United States. Adult and Adolescent Spectrum of HIV Disease Project Group.","volume":"8","author":"Wortley","year":"1994","journal-title":"AIDS"},{"key":"R21-16-20210202","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0264-410X(95)98261-8","article-title":"Influenza immunization for HIV-infected persons in Los Angeles.","volume":"13","author":"Sorvillo","year":"1995","journal-title":"Vaccine"},{"key":"R22-16-20210202","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/01.inf.0000166161.12087.94","article-title":"Challenges to vaccinating adolescents: vaccine implementation issues.","volume":"24","author":"Humiston","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R23-16-20210202","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archpedi.155.5.566","article-title":"Adolescent immunization practices: a national survey of US physicians.","volume":"155","author":"Schaffer","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R24-16-20210202","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1467-842X.2004.tb00636.x","article-title":"Predictors of incomplete immunisation in Victorian children.","volume":"28","author":"Haynes","year":"2004","journal-title":"Aust N Z J Public Health"},{"key":"R25-16-20210202","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1542\/peds.105.6.e73","article-title":"Immunization levels and risk factors for low immunization coverage among private practices.","volume":"105","author":"Kahane","year":"2000","journal-title":"Pediatrics"},{"key":"R26-16-20210202","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/bmj.332.7553.1312","article-title":"Differences in risk factors for partial and no immunisation in the first year of life: prospective cohort study.","volume":"332","author":"Samad","year":"2006","journal-title":"BMJ"},{"key":"R27-16-20210202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jadohealth.2006.12.013","article-title":"The impact of state policies on vaccine coverage by age 13 in an insured population.","volume":"40","author":"Olshen","year":"2007","journal-title":"J Adolesc Health"},{"key":"R28-16-20210202","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1054-139X(01)00252-X","article-title":"Factors associated with use of preventive dental and health services among U.S. adolescents.","volume":"29","author":"Yu","year":"2001","journal-title":"J Adolesc Health"},{"key":"R29-16-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3122\/jabfm.18.1.13","article-title":"Barriers to adolescent immunization: a survey of family physicians and pediatricians.","volume":"18","author":"Oster","year":"2005","journal-title":"J Am Board Fam Pract"},{"key":"R30-16-20210202","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/519165","article-title":"Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002.","volume":"196","author":"Gallagher","year":"2007","journal-title":"J Infect Dis"},{"key":"R31-16-20210202","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00002030-199708000-00010","article-title":"Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients.","volume":"11","author":"Fowke","year":"1997","journal-title":"AIDS"},{"key":"R32-16-20210202","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1086\/515170","article-title":"Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response.","volume":"28","author":"Fuller","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R33-16-20210202","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00002030-199404000-00008","article-title":"Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes.","volume":"8","author":"Kroon","year":"1994","journal-title":"AIDS"},{"key":"R35-16-20210202","first-page":"1100","article-title":"Vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2007.","volume":"57","author":"Jain","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R37-16-20210202","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2105\/AJPH.2013.301313","article-title":"An assessment of the performance of self-reported vaccination status for hepatitis B, National Health and Nutrition Examination Survey 1999-2008.","volume":"103","author":"Denniston","year":"2013","journal-title":"Am J Public Health"},{"key":"R40-16-20210202","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1473-3099(10)70116-X","article-title":"Do children infected with HIV receiving HAART need to be revaccinated?","volume":"10","author":"Sutcliffe","year":"2010","journal-title":"Lancet Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000001078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:10:08Z","timestamp":1620954608000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201605000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001078","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}